Form 4: Modular Medical Director Granted Stock Options

Modular Medical, Inc. director Jeff D. Goldberg was granted 7,500 stock options at an exercise price of $0.36, fully vested upon grant.

Summary

• Jeff D. Goldberg, a Director of Modular Medical, Inc. (MODD), reported the acquisition of derivative securities.
• The transaction involved the grant of 7,500 options to purchase common stock.
• The options have an exercise price of $0.36 per share.
• The grant date, exercisable date, and deemed execution date for the transaction was December 31, 2025.
• The options are fully vested and exercisable on the grant date.
• The options expire on December 31, 2035.
• This grant was made in accordance with the Issuer's Outside Director Compensation Plan.
• Following this transaction, Mr. Goldberg beneficially owns 7,500 derivative securities (options).

Sentiment

Score: 6

Explanation: Slightly positive, as it indicates routine director compensation and aligns management interests with shareholders, without any negative implications.

Positives

• The grant of stock options aligns the interests of Director Jeff D. Goldberg with those of shareholders, as his compensation is tied to the company's stock performance.
• The options were fully vested and exercisable on the grant date, providing immediate equity exposure to the director.

Future Outlook

The filing primarily details a past compensation event and does not contain explicit forward-looking statements or guidance beyond the expiration date of the options.

Management Comments

• The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

Industry Context

The grant of stock options to outside directors is a common practice across various industries, including medical technology, to attract and retain qualified board members and align their interests with long-term shareholder value.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity, with stock options or restricted stock units being standard components to incentivize long-term performance.
• The immediate vesting of options upon grant, as seen here, is not uncommon for director compensation, reflecting their ongoing strategic oversight rather than performance milestones tied to employment.
• While specific comparable companies or projects are not detailed in the filing, the structure of this option grant is consistent with general corporate governance practices for non-employee directors in publicly traded companies.

Corporate Governance

Related Party Transactions

• The grant of stock options to Director Jeff D. Goldberg constitutes a related party transaction, as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: Potential for minor dilution if options are exercised, but also benefits from increased alignment of director's interests with long-term stock performance.
• Director (Jeff D. Goldberg): Receives equity-based compensation, providing a direct financial incentive tied to the company's stock price appreciation.

Next Steps

• The director may choose to exercise the options at any point between the exercisable date (December 31, 2025) and the expiration date (December 31, 2035), assuming the stock price is above the exercise price of $0.36.

Key Dates

Keywords

MODD, Modular Medical, Jeff D. Goldberg, Stock Options, Director Compensation, SEC Form 4, Beneficial Ownership, Equity Grant